226 related articles for article (PubMed ID: 7727061)
1. Human 170 kDa and 180 kDa topoisomerases II bind preferentially to curved and left-handed linear DNA.
Bechert T; Diekmann S; Arndt-Jovin DJ
J Biomol Struct Dyn; 1994 Dec; 12(3):605-23. PubMed ID: 7727061
[TBL] [Abstract][Full Text] [Related]
2. Single-molecule study of DNA unlinking by eukaryotic and prokaryotic type-II topoisomerases.
Charvin G; Bensimon D; Croquette V
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9820-5. PubMed ID: 12902541
[TBL] [Abstract][Full Text] [Related]
3. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
[TBL] [Abstract][Full Text] [Related]
4. Interactions of Drosophila DNA topoisomerase II with left-handed Z-DNA in supercoiled minicircles.
Glikin GC; Jovin TM; Arndt-Jovin DJ
Nucleic Acids Res; 1991 Dec; 19(25):7139-44. PubMed ID: 1662808
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
Harker WG; Slade DL; Parr RL; Feldhoff PW; Sullivan DM; Holguin MH
Cancer Res; 1995 Apr; 55(8):1707-16. PubMed ID: 7712479
[TBL] [Abstract][Full Text] [Related]
6. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
Harker WG; Slade DL; Parr RL; Holguin MH
Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
[TBL] [Abstract][Full Text] [Related]
7. Interactions of anti-poly[d(G-br5C)] IgG with synthetic, viral and cellular Z DNAs.
Zarling DA; Arndt-Jovin DJ; McIntosh LP; Robert-Nicoud M; Jovin TM
J Biomol Struct Dyn; 1984 Mar; 1(5):1081-107. PubMed ID: 6400813
[TBL] [Abstract][Full Text] [Related]
8. Homologous and heterologous protein-protein interactions of human DNA topoisomerase IIalpha.
Kroll DJ
Arch Biochem Biophys; 1997 Sep; 345(2):175-84. PubMed ID: 9308887
[TBL] [Abstract][Full Text] [Related]
9. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
Chen M; Beck WT
Oncol Res; 1995; 7(2):103-11. PubMed ID: 7579726
[TBL] [Abstract][Full Text] [Related]
10. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
[TBL] [Abstract][Full Text] [Related]
11. Z-DNA binding and inhibition by GTP of Drosophila topoisomerase II.
Arndt-Jovin DJ; Udvardy A; Garner MM; Ritter S; Jovin TM
Biochemistry; 1993 May; 32(18):4862-72. PubMed ID: 8387819
[TBL] [Abstract][Full Text] [Related]
12. Sequence determinants of nuclear localization in the alpha and beta isoforms of human topoisomerase II.
Mirski SE; Gerlach JH; Cole SP
Exp Cell Res; 1999 Sep; 251(2):329-39. PubMed ID: 10471318
[TBL] [Abstract][Full Text] [Related]
13. Human topoisomerase II-DNA interaction study by using atomic force microscopy.
Alonso-Sarduy L; Roduit C; Dietler G; Kasas S
FEBS Lett; 2011 Oct; 585(19):3139-45. PubMed ID: 21907712
[TBL] [Abstract][Full Text] [Related]
14. Substrate specificity plays an important role in uncoupling the catalytic and scaffolding activities of rat testis DNA topoisomerase IIalpha.
Bakshi R; Galande S; Muniyappa K
J Biomol Struct Dyn; 2001 Apr; 18(5):749-60. PubMed ID: 11334111
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and two-parameter flow cytometric studies of DNA topoisomerase II alpha in human epithelial ovarian carcinoma and germ cell tumor.
Tanoguchi K; Sasano H; Yabuki N; Kikuchi A; Ito K; Sato S; Yajima A
Mod Pathol; 1998 Feb; 11(2):186-93. PubMed ID: 9504690
[TBL] [Abstract][Full Text] [Related]
16. Computational analysis of the chiral action of type II DNA topoisomerases.
Klenin K; Langowski J; Vologodskii A
J Mol Biol; 2002 Jul; 320(2):359-67. PubMed ID: 12079392
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
Gieseler F; Glasmacher A; Kämpfe D; Wandt H; Nuessler V; Valsamas S; Kunze J; Wilms K
Leukemia; 1996 Jul; 10(7):1177-80. PubMed ID: 8683999
[TBL] [Abstract][Full Text] [Related]
18. [Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 4. Topotecan binds preferably to the GC base pairs of DNA].
Strel'tsov SA; Mikheĭkin AL; Grokhovskiĭ SL; Oleĭnikov VA; Kudelina IA; Zhuze AL
Mol Biol (Mosk); 2002; 36(5):912-30. PubMed ID: 12391856
[TBL] [Abstract][Full Text] [Related]
19. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
[TBL] [Abstract][Full Text] [Related]
20. Interaction in vitro of type III intermediate filament proteins with supercoiled plasmid DNA and modulation of eukaryotic DNA topoisomerase I and II activities.
Li G; Tolstonog GV; Sabasch M; Traub P
DNA Cell Biol; 2002 Oct; 21(10):743-69. PubMed ID: 12443544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
